- Home
- LEA vs ACLX Comparison
LEA vs ACLX Comparison
Compare LEA & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEA
- ACLX
- Stock Information
- Founded
- LEA 1917
- ACLX 2015
- Country
- LEA United States
- ACLX United States
- Employees
- LEA N/A
- ACLX N/A
- Industry
- LEA Auto Parts:O.E.M.
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- LEA Consumer Discretionary
- ACLX Health Care
- Exchange
- LEA Nasdaq
- ACLX Nasdaq
- Market Cap
- LEA 5.1B
- ACLX 4.1B
- IPO Year
- LEA N/A
- ACLX 2022
- Fundamental
- Price
- LEA $105.65
- ACLX $76.19
- Analyst Decision
- LEA Buy
- ACLX Strong Buy
- Analyst Count
- LEA 11
- ACLX 13
- Target Price
- LEA $115.27
- ACLX $114.75
- AVG Volume (30 Days)
- LEA 537.3K
- ACLX 529.6K
- Earning Date
- LEA 10-23-2025
- ACLX 11-06-2025
- Dividend Yield
- LEA 2.82%
- ACLX N/A
- EPS Growth
- LEA N/A
- ACLX N/A
- EPS
- LEA 8.57
- ACLX N/A
- Revenue
- LEA $22,889,700,000.00
- ACLX $56,979,000.00
- Revenue This Year
- LEA N/A
- ACLX N/A
- Revenue Next Year
- LEA $2.13
- ACLX $174.18
- P/E Ratio
- LEA $12.74
- ACLX N/A
- Revenue Growth
- LEA N/A
- ACLX N/A
- 52 Week Low
- LEA $73.85
- ACLX $47.86
- 52 Week High
- LEA $115.47
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- LEA 47.91
- ACLX 63.27
- Support Level
- LEA $107.68
- ACLX $70.11
- Resistance Level
- LEA $111.87
- ACLX $73.10
- Average True Range (ATR)
- LEA 2.52
- ACLX 2.57
- MACD
- LEA -0.49
- ACLX 0.55
- Stochastic Oscillator
- LEA 1.59
- ACLX 79.16
About LEA Lear Corporation
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.